After deciding to withdraw Fycompa from the market last year, rather than sell it at Germany’s HTA agency approved price, Eisai’s epilepsy drug, Fycompa could be re-entered onto the market. Read more here. (Source: PMLiVE, 2/11/14).
After deciding to withdraw Fycompa from the market last year, rather than sell it at Germany’s HTA agency approved price, Eisai’s epilepsy drug, Fycompa could be re-entered onto the market. Read more here. (Source: PMLiVE, 2/11/14).